𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NMDA receptor function in mouse models of Huntington disease

✍ Scribed by Carlos Cepeda; Marjorie A. Ariano; Christopher R. Calvert; Jorge Flores-Hernández; Scott H. Chandler; Blair R. Leavitt; Michael R. Hayden; Michael S. Levine


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
328 KB
Volume
66
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Huntington disease (HD) is an autosomal dominant disorder in which degeneration of medium‐sized spiny striatal neurons occurs. The HD gene and the protein it encodes, huntingtin, have been identified but their functions remain unknown. Transgenic mouse models for HD have been developed and we examined responses of medium‐sized striatal neurons recorded in vitro to application of N‐methyl‐D‐aspartate (NMDA) in two of these. The first model (R6/2) expresses exon 1 of the human HD gene with approximately 150 CAG repeats. In the R6/2 an enhancement of currents induced by selective activation of NMDA receptors as well as an enhancement of intracellular Ca^2+^ flux occurred in both presymptomatic and symptomatic mice. These alterations appeared specific for the NMDA receptor because α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor‐mediated currents were reduced in symptomatic R6/2s. In R6/2 animals there were parallel increases in NMDA‐R1 and decreases in NMDA‐R2A/B subunit proteins as established by immunohistochemistry. The second model (YAC72) contains human genomic DNA spanning the full‐length gene and all its regulatory elements with 72 CAG repeats. The phenotypical expression of the disorder develops more gradually than in the R6/2. In YAC72 mice we found similar but less marked increases in responses of medium‐sized striatal neurons to NMDA. These findings indicate that alterations in NMDA receptor function may predispose striatal neurons to excitotoxic damage, leading to subsequent neuronal degeneration and underscore the functional importance of NMDA receptors in HD. J. Neurosci. Res. 66:525–539, 2001. © 2001 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Increased GABAergic function in mouse mo
✍ Carlos Cepeda; Amaal J. Starling; Nanping Wu; Oanh K. Nguyen; Besim Uzgil; Takah 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

## Abstract Huntington's disease (HD) is characterized by loss of striatal γ‐aminobutyric acid (GABA)ergic medium‐sized spiny projection neurons (MSSNs), whereas some classes of striatal interneurons are relatively spared. Striatal interneurons provide most of the inhibitory synaptic input to MSSNs

Enhanced sensitivity to N-methyl-D-aspar
✍ Michael S. Levine; Gloria J. Klapstein; Ahrin Koppel; Ehud Gruen; Carlos Cepeda; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 2 views

We used two mouse models of Huntington's disease (HD) to examine changes in glutamate receptor sensitivity and striatal electrophysiology. One model, a transgenic, consisted of mice expressing exon 1 of the human HD gene and carrying 141-157 CAG repeat sequences (R6/2 line). The second model, a CAG

Microglia density decreases with age in
✍ Li Ma; A. Jennifer Morton; Louise F.B. Nicholson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

## Abstract Huntington's disease (HD) is characterized by selective neuronal loss and reactive gliosis. In the R6/2 transgenic HD mouse model, there is no selective cell loss, although astrocytosis has been reported. Since there have been no previous studies on microglia in this model, we have unde

Assessment of adaptive functioning in hu
✍ Dr. Frederick W. Bylsma; Johannes Rothlind; Michelle R. Hall; Susan E. Folstein; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB

## Abstract The Huntington's Disease Activities of Daily Living (HD–ADL) scale is a 17‐item informant‐completed instrument for rating adaptive functioning in Huntington's disease (HD) patients. To assess the reliability and clinical correlates of the HD–ADL, it was administered along with the Mini‐